Johan Sjögren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Johan Sjögren has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Richard Ingemansson
Department of Cardiothoracic Surgery, Skåne University Hospital, Lund University, Lund, Sweden
5 shared publications Ronny Gustafsson
Department of Cardiothoracic Surgery, Lund University Hospital, Lund University, SE-221 85 Lund, Sweden
3 shared publications- Shahab Nozohoor
Department of Cardiothoracic and Vascular Surgery, Lund University and Skane University Hospital , Lund SE-221 85
3 shared publications - Anders Albåge
Department of Cardiothoracic Surgery and Anesthesiology, University Hospital , Uppsala
2 shared publications - Anders Holmgren
Department of Public Health and Clinical Medicine, Umeå University , Umeå
2 shared publications - Anders Wickbom
Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine and Health, Örebro University Hospital , Örebro
2 shared publications
Latest Publications
- Open Access
- 29 March 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (4)
High incidence of permanent pacemaker after Cox-maze IV and mitral valve surgery: a nationwide registry-based study
OBJECTIVES: This study evaluated the long-term risk of permanent pacemaker implantation following Cox-maze IV (CMIV) and concurrent mitral valve surgery. METHODS: A retrospective, nationwide, registry-based analysis was conducted on postoperative permanent pacemaker implantation in 397 patients with symptomatic mitral valve insufficiency and atrial fibrillation who underwent CMIV and mitral valve surgery in Sweden between 2009 and 2017. They were compared to a registry group of 346 patients with atrial fibrillation who underwent mitral valve surgery without surgical ablation during 2014–2017. The follow-up ended on 30 September 2022. RESULTS: CMIV patients were on average 4 years younger and had lower surgical risk than registry patients. More CMIV patients underwent early (60% of early pacemaker indications in both groups, and sinus node dysfunction was the indication for late pacemaker implantation in 48% in the CMIV group. CONCLUSIONS: Patients undergoing CMIV concomitant with mitral valve surgery have a higher rate of postoperative pacemaker implantation compared to patients with atrial fibrillation undergoing mitral valve surgery alone. Sinus node dysfunction was the main indication for late pacemaker among CMIV patients.
- 29 March 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (4)
Open AccessHigh incidence of permanent pacemaker after Cox-maze IV and mitral valve surgery: a nationwide registry-based study
OBJECTIVES: This study evaluated the long-term risk of permanent pacemaker implantation following Cox-maze IV (CMIV) and concurrent mitral valve surgery. METHODS: A retrospective, nationwide, registry-based analysis was conducted on postoperative permanent pacemaker implantation in 397 patients with symptomatic mitral valve insufficiency and atrial fibrillation who underwent CMIV and mitral valve surgery in Sweden between 2009 and 2017. They were compared to a registry group of 346 patients with atrial fibrillation who underwent mitral valve surgery without surgical ablation during 2014–2017. The follow-up ended on 30 September 2022. RESULTS: CMIV patients were on average 4 years younger and had lower surgical risk than registry patients. More CMIV patients underwent early (60% of early pacemaker indications in both groups, and sinus node dysfunction was the indication for late pacemaker implantation in 48% in the CMIV group. CONCLUSIONS: Patients undergoing CMIV concomitant with mitral valve surgery have a higher rate of postoperative pacemaker implantation compared to patients with atrial fibrillation undergoing mitral valve surgery alone. Sinus node dysfunction was the main indication for late pacemaker among CMIV patients.
- Open Access
- 10 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (2) , oeaf027
Causes and clinical impact of initial misdiagnosis of acute type A aortic dissection
Aims: The high mortality in untreated acute type A aortic dissection (ATAAD) stresses the need for prompt diagnosis and immediate surgical treatment. Our aim was to evaluate the frequency and clinical impact of misdiagnosis and delayed diagnosis of ATAAD. Methods and results: This was a single-centre, retrospective, observational study including all ATAAD patients with available admission charts between 2001 and 2021 in an area of 1.9 million inhabitants in southern Sweden. The primary endpoints were initial misdiagnosis, delayed diagnosis, and 30-day mortality. Surgical treatment was a secondary endpoint. Independent predictors of misdiagnosis and 30-day mortality were identified by multivariable logistic regression and subgroup analyses by severity of clinical presentation were performed. There were 556 patients included in the study (418 surgically treated and 138 non-surgically treated), and 45.3% were initially misdiagnosed. Misdiagnosed patients were more often female (47.6 vs. 35.9%; P = 0.005) and demonstrated significantly lower rates of syncope, hypotensive shock, and malperfusion. Patients without signs of malperfusion subjected to diagnostic delay were less likely offered surgical treatment (74.0 vs. 91.5%; P < 0.001) and had higher 30-day mortality (21.3 vs. 10.8%; P = 0.040). Female sex was an independent predictor of misdiagnosis (OR: 1.748; 95% CI 1.145–2.668; P = 0.010), but neither misdiagnosis nor delayed diagnosis were independent predictors of 30-day mortality. Conclusion: Although misdiagnosis and delayed diagnosis did not influence overall 30-day mortality, delayed diagnosis led to significantly higher 30-day mortality in the large group of patients presenting without signs of malperfusion, likely caused by the observed higher risk of being denied surgical treatment.
- 10 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (2) , oeaf027
Open AccessCauses and clinical impact of initial misdiagnosis of acute type A aortic dissection
Aims: The high mortality in untreated acute type A aortic dissection (ATAAD) stresses the need for prompt diagnosis and immediate surgical treatment. Our aim was to evaluate the frequency and clinical impact of misdiagnosis and delayed diagnosis of ATAAD. Methods and results: This was a single-centre, retrospective, observational study including all ATAAD patients with available admission charts between 2001 and 2021 in an area of 1.9 million inhabitants in southern Sweden. The primary endpoints were initial misdiagnosis, delayed diagnosis, and 30-day mortality. Surgical treatment was a secondary endpoint. Independent predictors of misdiagnosis and 30-day mortality were identified by multivariable logistic regression and subgroup analyses by severity of clinical presentation were performed. There were 556 patients included in the study (418 surgically treated and 138 non-surgically treated), and 45.3% were initially misdiagnosed. Misdiagnosed patients were more often female (47.6 vs. 35.9%; P = 0.005) and demonstrated significantly lower rates of syncope, hypotensive shock, and malperfusion. Patients without signs of malperfusion subjected to diagnostic delay were less likely offered surgical treatment (74.0 vs. 91.5%; P < 0.001) and had higher 30-day mortality (21.3 vs. 10.8%; P = 0.040). Female sex was an independent predictor of misdiagnosis (OR: 1.748; 95% CI 1.145–2.668; P = 0.010), but neither misdiagnosis nor delayed diagnosis were independent predictors of 30-day mortality. Conclusion: Although misdiagnosis and delayed diagnosis did not influence overall 30-day mortality, delayed diagnosis led to significantly higher 30-day mortality in the large group of patients presenting without signs of malperfusion, likely caused by the observed higher risk of being denied surgical treatment.
- Open Access
- 18 November 2024
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 39 (6)
Risk of neurologic events after surgery for mitral valve insufficiency and concomitant Cox-maze IV procedure for atrial fibrillation. A nationwide register-based study
Analysis of the long-term risks of ischaemic stroke and cerebral bleeding in patients with atrial fibrillation after mitral valve surgery and concomitant Cox-maze IV procedure. In total, 397 patients with symptomatic degenerative mitral valve insuffciency and atrial fibrillation, underwent mitral valve surgery and Cox-maze IV in Sweden between 2009–2017. In this retrospective nationwide analysis, patients were followed in national patient registers until September 30, 2022. There were four deaths within 30 days (1.0%). Mean follow-up was 8.7 (0.1–13.4) years. Survival without ischaemic stroke or cerebral Haemorrhage at five and ten years were 90% and 74%, respectively. Nineteen patients experienced an ischaemic stroke, of which four were fatal. Five of 34 patients (14.7%) with a history of stroke preoperatively experienced ischaemic stroke during follow-up. The linearized rate of ischaemic stroke per patient-year was 0.6% and was similar regardless of left atrial appendage closure during surgery or whether a mechanical valve was inserted. The observed ischaemic stroke rate was lower than the predicted rate for all CHA2DS2-VASc score groups. Fourteen patients suffered cerebral bleeding, of which three were fatal. Patients who experienced cerebral bleeding were older, and had higher mechanical valve implantation rate than those without cerebral bleeding. Surgery for mitral valve insufficiency and concomitant Cox-maze IV can be performed with low perioperative risk. There is a low continuing risk of stroke long-term postoperatively that correlates with higher CHA2DS2-VASc score. Patients with preoperative stroke are at increased risk of postoperative stroke despite atrial fibrillation surgery.
- 18 November 2024
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 39 (6)
Open AccessRisk of neurologic events after surgery for mitral valve insufficiency and concomitant Cox-maze IV procedure for atrial fibrillation. A nationwide register-based study
Analysis of the long-term risks of ischaemic stroke and cerebral bleeding in patients with atrial fibrillation after mitral valve surgery and concomitant Cox-maze IV procedure. In total, 397 patients with symptomatic degenerative mitral valve insuffciency and atrial fibrillation, underwent mitral valve surgery and Cox-maze IV in Sweden between 2009–2017. In this retrospective nationwide analysis, patients were followed in national patient registers until September 30, 2022. There were four deaths within 30 days (1.0%). Mean follow-up was 8.7 (0.1–13.4) years. Survival without ischaemic stroke or cerebral Haemorrhage at five and ten years were 90% and 74%, respectively. Nineteen patients experienced an ischaemic stroke, of which four were fatal. Five of 34 patients (14.7%) with a history of stroke preoperatively experienced ischaemic stroke during follow-up. The linearized rate of ischaemic stroke per patient-year was 0.6% and was similar regardless of left atrial appendage closure during surgery or whether a mechanical valve was inserted. The observed ischaemic stroke rate was lower than the predicted rate for all CHA2DS2-VASc score groups. Fourteen patients suffered cerebral bleeding, of which three were fatal. Patients who experienced cerebral bleeding were older, and had higher mechanical valve implantation rate than those without cerebral bleeding. Surgery for mitral valve insufficiency and concomitant Cox-maze IV can be performed with low perioperative risk. There is a low continuing risk of stroke long-term postoperatively that correlates with higher CHA2DS2-VASc score. Patients with preoperative stroke are at increased risk of postoperative stroke despite atrial fibrillation surgery.
- Open Access
- 1 February 2011
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 12 (2) , 117-120
Negative-pressure wound therapy following cardiac surgery: bleeding complications and 30-day mortality in 176 patients with deep sternal wound infection
Negative-pressure wound therapy (NPWT) has been used for the treatment of deep sternal wound infection (DSWI) with promising results. However, questi
- 1 February 2011
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 12 (2) , 117-120
Open AccessNegative-pressure wound therapy following cardiac surgery: bleeding complications and 30-day mortality in 176 patients with deep sternal wound infection
Negative-pressure wound therapy (NPWT) has been used for the treatment of deep sternal wound infection (DSWI) with promising results. However, questi
- 31 May 2010
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 89 (5) , 1706
Reply
- 1 February 2009
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 28 (2) , S194-194
370: Heart Transplantation with Non-Identical Compatible ABO Blood-Groups: Impact on Early Rejection and Long-Term Survival
- 1 February 2009
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 28 (2) , S194-194
370: Heart Transplantation with Non-Identical Compatible ABO Blood-Groups: Impact on Early Rejection and Long-Term Survival
- 29 October 2008
- Vol. 105 (40) , 2773-6
[Vacuum-assisted closure yields good clinical results. Good healing in complicated wounds--deep sternal infections an example].
- 29 October 2008
- Vol. 105 (40) , 2773-6
[Vacuum-assisted closure yields good clinical results. Good healing in complicated wounds--deep sternal infections an example].
- 20 May 2008
- Published by Wiley in International Wound Journal
- Vol. 5 (2) , 216-223
Vacuum‐assisted closure therapy for deep sternal wound infections: the impact of learning curve on survival and predictors for late mortality
The aim of this study was to evaluate the possible learning curve effects on survival during the introduction of vacuum‐assisted closure (VAC) therapy in patients with deep sternal wound infection (DSWI). Furthermore, predictors of late mortality were analysed and causes of late death were examined. Fifty‐three patients (early Group, n = 26, January 1999 to July 2001 versus late group, n = 27, August 2001 to March 2003) were all treated with VAC for DSWI. A follow‐up was carried out in September 2006. Multivariate analyses were used to evaluate the predictors of late mortality. The 90‐day mortality was 0% in both groups. The survival rates at 5 years were 69·2 ± 9·1% (early group) versus 58·5 ± 11·7% (late group), P = ns (non significant). The time interval from cardiac surgery to diagnosis of DSWI and prolonged VAC therapy were identified as independent predictors of late mortality. Our concept for VAC therapy in DSWI seems to be readily introduced in clinical practice. There was no difference in survival between our initial cases and later cases. Late diagnosis and prolonged wound therapy were identified as predictors for late mortality.
- 20 May 2008
- Published by Wiley in International Wound Journal
- Vol. 5 (2) , 216-223
Vacuum‐assisted closure therapy for deep sternal wound infections: the impact of learning curve on survival and predictors for late mortality
The aim of this study was to evaluate the possible learning curve effects on survival during the introduction of vacuum‐assisted closure (VAC) therapy in patients with deep sternal wound infection (DSWI). Furthermore, predictors of late mortality were analysed and causes of late death were examined. Fifty‐three patients (early Group, n = 26, January 1999 to July 2001 versus late group, n = 27, August 2001 to March 2003) were all treated with VAC for DSWI. A follow‐up was carried out in September 2006. Multivariate analyses were used to evaluate the predictors of late mortality. The 90‐day mortality was 0% in both groups. The survival rates at 5 years were 69·2 ± 9·1% (early group) versus 58·5 ± 11·7% (late group), P = ns (non significant). The time interval from cardiac surgery to diagnosis of DSWI and prolonged VAC therapy were identified as independent predictors of late mortality. Our concept for VAC therapy in DSWI seems to be readily introduced in clinical practice. There was no difference in survival between our initial cases and later cases. Late diagnosis and prolonged wound therapy were identified as predictors for late mortality.
- 31 May 2007
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 133 (5) , 1154-1162
Hemodynamic effects of vacuum-assisted closure therapy in cardiac surgery: Assessment using magnetic resonance imaging
- 31 May 2007
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 133 (5) , 1154-1162
Hemodynamic effects of vacuum-assisted closure therapy in cardiac surgery: Assessment using magnetic resonance imaging
- Top Cited PapersOpen Access
- 1 December 2006
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 30 (6) , 898-905
Poststernotomy mediastinitis: a review of conventional surgical treatments, vacuum-assisted closure therapy and presentation of the Lund University Hospital mediastinitis algorithm
Poststernotomy mediastinitis, also commonly called deep sternal wound infection, is one of the most feared complications in patients undergoing cardiac surgery. The overall incidence of poststernotomy mediastinitis is relatively low, between 1% and 3%, however, this complication is associated with a significant mortality, usually reported to vary between 10% and 25%. At the present time, there is no general consensus regarding the appropriate surgical approach to mediastinitis following open-heart surgery and a wide range of wound-healing strategies have been established for the treatment of poststernotomy mediastinitis during the era of modern cardiac surgery. Conventional forms of treatment usually involve surgical revision with open dressings or closed irrigation, or reconstruction with vascularized soft tissue flaps such as omentum or pectoral muscle. Unfortunately, procedure-related morbidity is relatively frequent when using conventional treatments and the long-term clinical outcome has been unsatisfying. Vacuum-assisted closure is a novel treatment with an ingenious mechanism. This wound-healing technique is based on the application of local negative pressure to a wound. During the application of negative pressure to a sternal wound several advantageous features from conventional surgical treatment are combined. Recent publications have demonstrated encouraging clinical results, however, observations are still rather limited and the underlying mechanisms are largely unknown. This review provides an overview of the etiology and common risk factors for deep sternal wound infections and presents the historical development of conventional therapies. We also discuss the current experiences with VAC therapy in poststernotomy mediastinitis and summarize the current knowledge on the mechanisms by which VAC therapy promotes wound healing. Finally, we suggest a structured algorithm for using VAC therapy for treatment of poststernotomy mediastinitis in clinical practice.
- 1 December 2006
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 30 (6) , 898-905
Top Cited PapersOpen AccessPoststernotomy mediastinitis: a review of conventional surgical treatments, vacuum-assisted closure therapy and presentation of the Lund University Hospital mediastinitis algorithm
Poststernotomy mediastinitis, also commonly called deep sternal wound infection, is one of the most feared complications in patients undergoing cardiac surgery. The overall incidence of poststernotomy mediastinitis is relatively low, between 1% and 3%, however, this complication is associated with a significant mortality, usually reported to vary between 10% and 25%. At the present time, there is no general consensus regarding the appropriate surgical approach to mediastinitis following open-heart surgery and a wide range of wound-healing strategies have been established for the treatment of poststernotomy mediastinitis during the era of modern cardiac surgery. Conventional forms of treatment usually involve surgical revision with open dressings or closed irrigation, or reconstruction with vascularized soft tissue flaps such as omentum or pectoral muscle. Unfortunately, procedure-related morbidity is relatively frequent when using conventional treatments and the long-term clinical outcome has been unsatisfying. Vacuum-assisted closure is a novel treatment with an ingenious mechanism. This wound-healing technique is based on the application of local negative pressure to a wound. During the application of negative pressure to a sternal wound several advantageous features from conventional surgical treatment are combined. Recent publications have demonstrated encouraging clinical results, however, observations are still rather limited and the underlying mechanisms are largely unknown. This review provides an overview of the etiology and common risk factors for deep sternal wound infections and presents the historical development of conventional therapies. We also discuss the current experiences with VAC therapy in poststernotomy mediastinitis and summarize the current knowledge on the mechanisms by which VAC therapy promotes wound healing. Finally, we suggest a structured algorithm for using VAC therapy for treatment of poststernotomy mediastinitis in clinical practice.